1. Sequence specificity of amylin-insulin interaction: a fragment-based insulin fibrillation inhibition study.
- Author
-
Ratha, Bhisma Narayan, Kar, Rajiv K., Kalita, Sujan, Kalita, Sourav, Raha, Sreyan, Singha, Achintya, Garai, Kanchan, Mandal, Bhubaneswar, and Bhunia, Anirban
- Subjects
- *
AMYLIN , *INSULIN therapy , *TYPE 2 diabetes treatment , *EXCIPIENTS , *BENZOIC acid - Abstract
Abstract Subcutaneous insulin delivery serves as the major treatment for the ever-increasing spread of type II diabetes worldwide. However, long-term exposure to insulin results in local aggregates at the site of injection. This therapeutic concern accentuates the need to develop newer effective excipients to stabilize the insulin in pharmaceutical formulations. The fact that in normal physiological conditions, insulin interacts with the amylin hormone co-secreted from the pancreas, we targeted a peptide-mimetic approach based on the amylin sequence. The amylin-fibrillating core (NL6- N22FGAIL27 from the human Islet Amyloid Poly-Peptide) and its derivative NFGAXL (NL6X, X = 2-aminobenzoic acid) were used as potential inhibitory peptides against insulin amyloidogenesis. The fibrillation kinetics in the presence of the inhibitors was studied using an array of biophysical and microscopic techniques. High-resolution NMR spectroscopy enabled probing of the inhibitory interaction at an atomic resolution. Our results highlight the potential of using the naturally evolved NL6 peptide as an effective inhibitor against insulin fibrillation. Graphical abstract Unlabelled Image Highlights • The study highlights the amyloid inhibition. • The fibrillating core of amylin is capable of inhibiting insulin fibrillation. • The interaction between the amylin fibrillating core and insulin is rendered upon introduction of peptide-mimetic approach. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF